These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 51577

  • 1. [Drug therapy of malignant tumors of the skin. Bleomycin].
    Ocaña Sierra J.
    Actas Dermosifiliogr; 1975; 66(3-4):159-78. PubMed ID: 51577
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experience with NK 631 in malignant tumors of skin (author's transl)].
    Nobe O, Kubo H, Yoshii K, Tashiro M.
    Jpn J Antibiot; 1979 Mar; 32(3):463-9. PubMed ID: 86628
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Extensive disseminated cutaneous neoplasms; role of cytophotometry in determining the correct chemotherapy].
    Coninx P, Liautaud F, Kalis B, Pourny C, Cattan A.
    Ann Dermatol Venereol; 1978 Apr; 105(4):443-5. PubMed ID: 80148
    [No Abstract] [Full Text] [Related]

  • 5. [Bleomycin and skin neoplasms].
    De Bast C, Moriame N, Wanet J, Ledoux M, Achten G, Kenis Y.
    Arch Belg Dermatol Syphiligr; 1971 Apr; 27(3):233-9. PubMed ID: 4114613
    [No Abstract] [Full Text] [Related]

  • 6. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM, Ohnuma T, Ambinder EP, Holland JF.
    Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
    [No Abstract] [Full Text] [Related]

  • 7. Clinical study with bleomycin: tolerance to twice weekly dosage.
    Onuma T, Selawry OS, Holland JF, DeVita VT, Shedd DP, Hansen HH, Muggia FM.
    Cancer; 1972 Oct; 30(4):914-22. PubMed ID: 4116909
    [No Abstract] [Full Text] [Related]

  • 8. Current status of PEP bleomycin studies in Japan.
    Ikeda S, Miyasato H, Nakayama H, Tajima K, Sato A.
    Recent Results Cancer Res; 1981 Oct; 76():41-60. PubMed ID: 6165056
    [Abstract] [Full Text] [Related]

  • 9. [Results with the cytostatic agent bleomycin in tumour therapy (author's transl)].
    Baumgartner G.
    Wien Klin Wochenschr; 1973 Oct 19; 85(42):686-92. PubMed ID: 4128921
    [No Abstract] [Full Text] [Related]

  • 10. Effect of bleomycin on squamous cell carcinoma: preliminary observations.
    Van Rooyen CE, Haldane EV.
    N S Med Bull; 1972 Oct 19; 51(5):144-50. PubMed ID: 4116503
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R, Bernheim J, Cumps E, Buyse M, Kenis Y.
    Cancer Treat Rep; 1981 Oct 19; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract] [Full Text] [Related]

  • 14. [Anticancer treatment and bromelains].
    Gerard G.
    Agressologie; 1972 Oct 19; 13(4):261-74. PubMed ID: 4678520
    [No Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
    De Wasch G, Bernheim J, Michel J, Lejeune F, Kenis Y.
    Cancer Treat Rep; 1976 Sep 19; 60(9):1273-6. PubMed ID: 65222
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin.
    Tomio L, Calzavara F, Zorat PL, Corti L, Polico C, Reddi E, Jori G, Mandoliti G.
    Prog Clin Biol Res; 1984 Sep 19; 170():829-40. PubMed ID: 6531372
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.